RecruitingNCT03113552

Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty


Sponsor

Centre Hospitalier Universitaire, Amiens

Enrollment

1,500 participants

Start Date

Feb 4, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

Mitral insufficiency (MI) accounts for 24% of adult valvulopathies and affects 7% of subjects older than 75 years. They are the second leading cause of valvulopathy in Europe. The most common etiology is the associated valvular prolapse. Mitral surgery remains the reference treatment for symptomatic MI. The success of this procedure depends on the mitral valve geometry and the location of the prolapse. The site of the prolapse, whether monovalvular, localized to the posterior or anterior leaflet, or bivalvular, influences the possibilities and probably the long-term results of the plasty.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patients operated between 1988 and 2011
  • Presence of a valvular prolapse diagnosed by echocardiography
  • Possibility of a complete clinical evaluation at the time of the initial echocardiography

Exclusion Criteria3

  • Ischemic MI (including papillary muscle rupture)
  • Presence of significant aortic valvulopathy, mitral valvular stenosis or congenital disease
  • History of cardiac surgery

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

CHU Amiens Picardie

Amiens, Picardie, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03113552


Related Trials